R. Zimmer

Phase I Trial of Combretastatin A-4 Phosphate with Carboplatin

K. Flaherty, M. Rosen, M. Schnall, 2005, Clinical Cancer Research.

A prospective study of continuous intravenous milrinone therapy for status IB patients awaiting heart transplant at home.

M. Jessup, L. Goldberg, A. Kao, 2004, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Coronavirus disease 2019 in heart transplant recipients: Risk factors, immunosuppression, and outcomes

S. Najjar, D. Mancini, K. Margulies, 2021, The Journal of Heart and Lung Transplantation.

Characteristics and Outcomes of COVID-19 in Patients on Left Ventricular Assist Device Support

S. Najjar, D. Mancini, J. Wald, 2021, Circulation. Heart failure.

Pharmacodynamic study of the raf kinase inhibitor BAY 43-9006: Mechanisms of hypertension.

K. Flaherty, M. Rosen, P. O'dwyer, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I trial of the antivascular agent combretastatin A4 phosphate on a 5-day schedule to patients with cancer: magnetic resonance imaging evidence for altered tumor blood flow.

Weijing Sun, Daniel G Haller, Mark Rosen, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Use of automated external defibrillators at NCAA Division I universities.

B. Sennett, J. Drezner, K. Rogers, 2005, Medicine and science in sports and exercise.

Use of Automated External Defibrillators at Division I Universities: Prevalence, Outcomes, and Cost Analysis

B. Sennett, J. Drezner, K. Rogers, 2005 .